Structures by: Ghalib R. M.
Total: 17
2-(1,3-Dioxoindan-2-yl)isoquinoline-1,3,4-trione
C18H9NO5
Acta Crystallographica Section E (2015) 71, 1 o6-o7
a=12.60800(10)Å b=13.6849(2)Å c=8.44670(10)Å
α=90° β=102.0510(10)° γ=90°
2-Acetonyl-2-hydroxyindan-1,3-dione
C12H10O4
Acta Crystallographica Section E (2009) 65, 6 o1209
a=18.1190(2)Å b=8.81350(10)Å c=6.25850(10)Å
α=90.00° β=90.00° γ=90.00°
Indeno[1,2-b]quinoxalin-11-one
C15H8N2O
Acta Crystallographica Section E (2010) 66, 6 o1494
a=23.688(3)Å b=3.7862(5)Å c=11.5730(16)Å
α=90.00° β=90.00° γ=90.00°
Cyclohexane-1,3-diyl bis(<i>N</i>-phenylcarbamate)
C20H22N2O4
Acta Crystallographica Section E (2010) 66, 9 o2406-o2407
a=38.356(7)Å b=9.5453(16)Å c=9.8472(16)Å
α=90.00° β=91.034(3)° γ=90.00°
3-(2-Amino-5-nitroanilino)-5,5-dimethylcyclohex-2-en-1-one 0.25-hydrate
C14H17N3O3,0.25(H2O)
Acta Crystallographica Section E (2010) 66, 9 o2414-o2415
a=18.90430(10)Å b=16.70480(10)Å c=17.8806(2)Å
α=90.00° β=102.4430(10)° γ=90.00°
2,3-Dimethyl-6-nitroquinoxaline
C10H9N3O2
Acta Crystallographica Section E (2010) 66, 7 o1830-o1831
a=7.1125(7)Å b=22.490(2)Å c=12.9596(10)Å
α=90.00° β=115.026(4)° γ=90.00°
2,2,4-Trimethyl-7-nitro-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-5-ium perchlorate
C12H16N3O2,ClO4
Acta Crystallographica Section E (2010) 66, 7 o1845
a=21.046(7)Å b=11.818(3)Å c=15.636(6)Å
α=90.00° β=132.176(9)° γ=90.00°
1,3,3-Trimethyl-1,2,3,4-tetrahydropyrido[1,2-<i>a</i>]benzimidazol-1-ol
C14H18N2O
Acta Crystallographica Section E (2010) 66, 7 o1832
a=9.615(5)Å b=8.194(4)Å c=15.965(8)Å
α=90.00° β=99.601(12)° γ=90.00°
7,7',8,8'-tetramethoxy-4,4'-dimethyl-3,3'-bicoumarin
C24H22O8
Acta Crystallographica Section E (2009) 65, 6 o1294-o1295
a=21.715(9)Å b=7.138(3)Å c=15.511(6)Å
α=90.00° β=121.801(5)° γ=90.00°
7,7',8,8'-Tetramethoxy-4,4'-dimethyl-3,5'-bichromene-2,2'-dione
C24H22O8
Acta Crystallographica Section E (2009) 65, 6 o1322-o1323
a=9.47240(10)Å b=23.4766(3)Å c=9.35250(10)Å
α=90.00° β=96.2540(10)° γ=90.00°
Ethyl (3a-<i>cis</i>)-3a,8b-dihydroxy-2-methyl- 4-oxo-3a,8b-dihydro-4<i>H</i>-indeno[1,2-<i>b</i>]furan-3-carboxylate monohydrate
C15H14O6,H2O1
Acta Crystallographica Section E (2009) 65, 11 o2616
a=7.9740(4)Å b=16.7524(8)Å c=11.0041(5)Å
α=90.00° β=98.833(2)° γ=90.00°
2-(4-Methylcyclohex-3-enyl)propan-2-yl <i>N</i>-phenylcarbamate
C17H23NO2
Acta Crystallographica Section E (2010) 66, 8 o1889-o1890
a=19.3067(19)Å b=9.0058(9)Å c=8.9521(9)Å
α=90.00° β=100.964(3)° γ=90.00°
9-(3,4-Dimethoxyphenyl)-3,4,5,6,7,9-hexahydroxanthene-1,8(2<i>H</i>)-dione
C21H22O5
Acta Crystallographica Section E (2011) 67, 6 o1449
a=8.7733(3)Å b=15.2246(5)Å c=14.6646(4)Å
α=90.00° β=116.891(2)° γ=90.00°
9-(3,4-Dimethoxyphenyl)-3,3,6,6-tetramethyl-4,5,6,9-tetrahydro- 3<i>H</i>-xanthene-1,8(2<i>H</i>,7<i>H</i>)-dione
C25H30O5
Acta Crystallographica Section E (2011) 67, 7 o1719-o1720
a=9.4895(7)Å b=10.2283(7)Å c=23.3218(16)Å
α=85.872(4)° β=86.537(4)° γ=74.425(3)°
3a,8a-Dihydroxy-1,3,3a,8a-tetrahydroindeno[1,2-<i>d</i>]imidazole-2,8-dione
C10H8N2O4
Acta Crystallographica Section E (2011) 67, 6 o1525
a=6.7914(2)Å b=7.3201(2)Å c=9.5006(3)Å
α=94.2580(10)° β=102.7730(10)° γ=93.7250(10)°
2-Methyl-5-nitro-1<i>H</i>-benzimidazole monohydrate
C8H7N3O2,H2O
Acta Crystallographica Section E (2011) 67, 6 o1523-o1524
a=6.9051(10)Å b=7.1309(11)Å c=10.0653(15)Å
α=79.421(3)° β=73.062(3)° γ=67.517(3)°
2-Hydroxy-2-(3-oxobutan-2-yl)indan-1,3-dione
C13H12O4
Acta Crystallographica Section E (2011) 67, 7 o1576
a=9.5080(5)Å b=6.7200(4)Å c=17.5195(9)Å
α=90.00° β=101.0440(10)° γ=90.00°